brolucizumab (brolucizumab-dbll)
for Macular Degeneration

Brolucizumab-dbll is an eye injection used to treat the wet form of age-related macular degeneration (AMD). Made from a human antibody fragment, it works by blocking the growth of abnormal blood vessels under the retina that can leak blood and fluid, helping to reduce swelling and preserve vision.

Heart
Medication Guide Icon Medication Guide
New Articles Icon New Articles
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Macular Degeneration